MFHAS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.468800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.618600E-01
Normal-vs-Stage2
7.745600E-01
Normal-vs-Stage3
3.513000E-01
Normal-vs-Stage4
7.626000E-01
Stage1-vs-Stage2
5.345800E-01
Stage1-vs-Stage3
6.719400E-01
Stage1-vs-Stage4
3.243400E-01
Stage2-vs-Stage3
3.051000E-01
Stage2-vs-Stage4
4.240200E-01
Stage3-vs-Stage4
1.881770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.900400E-01
Normal-vs-AfricanAmerican
5.776200E-01
Normal-vs-Asian
4.884800E-01
Caucasian-vs-AfricanAmerican
5.370300E-02
Caucasian-vs-Asian
5.724400E-01
AfricanAmerican-vs-Asian
1.065220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.401400E-01
Normal-vs-Female
6.705400E-01
Male-vs-Female
8.414000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.624800E-01
Normal-vs-Age(41-60Yrs)
8.875200E-01
Normal-vs-Age(61-80Yrs)
5.931600E-01
Normal-vs-Age(81-100Yrs)
3.059000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.191400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.390000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.826400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.804040E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.176430E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.427000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.222600E-01
Normal-vs-Daily Drinker
1.544840E-01
Normal-vs-Weekly Drinker
8.633800E-01
Normal-vs-Occasional Drinker
3.761200E-01
Normal-vs-Social Drinker
9.084400E-01
Non Drinker-vs-Daily Drinker
1.454810E-01
Non Drinker-vs-Weekly Drinker
5.036400E-01
Non Drinker-vs-Occasional Drinker
7.141400E-01
Non Drinker-vs-Social Drinker
1.110220E-01
Daily Drinker-vs-Weekly Drinker
1.434850E-01
Daily Drinker-vs-Occasional Drinker
3.595800E-01
Daily Drinker-vs-Social Drinker
1.538210E-02
Weekly Drinker-vs-Occasional Drinker
3.680000E-01
Weekly Drinker-vs-Social Drinker
6.269800E-01
Occasional Drinker-vs-Social Drinker
1.121370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.851200E-01
Normal-vs-Grade 2
3.513900E-02
Normal-vs-Grade 3
4.481700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.405250E-01
Grade 1-vs-Grade 3
8.855500E-02
Grade 1-vs-Grade 4
2.851200E-01
Grade 2-vs-Grade 3
6.876000E-01
Grade 2-vs-Grade 4
3.513900E-02
Grade 3-vs-Grade 4
4.481700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.324000E-01
Normal-vs-NonDiabetic
4.466200E-01
Diabetic-vs-NonDiabetic
3.264200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.812400E-01
Normal-vs-NoPancreatitis
5.578200E-01
Pancreatitis-vs-NoPancreatitis
8.445600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.965600E-01
Normal-vs-N1
7.507400E-01
N0-vs-N1
1.929360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.723600E-01
Normal-vs-TP53-NonMutant
5.941800E-01
TP53-Mutant-vs-TP53-NonMutant
7.147400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
